Navigation Links
Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
Date:6/11/2008

X experienced improvements in disease activity as measured by DAS28. Seventy-six percent of patients in the combined golimumab group were classified as DAS28 (CRP) responders, and 38 percent achieved DAS 28 remission, compared with 61 percent and 28 percent of patients receiving placebo and MTX, respectively (p<0.001 for responders and p=0.031 for remission).

"We are encouraged by the findings of both of these Phase 3 studies," said Robert J. Spiegel, M.D., chief medical officer, Schering-Plough Research Institute. "Golimumab holds great promise as an anti-TNF therapy for patients who may benefit from monthly subcutaneous injections for RA and related rheumatic diseases."

In March 2008, Centocor Inc. and Schering-Plough Corporation (NYSE: SGP) announced that a Marketing Authorization Application (MAA) had been submitted to the European Medicines Agency requesting the approval of golimumab as a monthly subcutaneous treatment for adults with RA, psoriatic arthritis and ankylosing spondylitis. The initial submission and Phase 3 development programs are unprecedented among anti-TNF-alpha therapies, as they mark the first time that an MAA has been proposed for review inclusive of three unique disease states. Golimumab, Centocor's and Schering-Plough's next-generation human anti-TNF-alpha monoclonal antibody, is being studied as an every four-week subcutaneous injection and an intravenous (IV) infusion therapy.

About the GO-FORWARD Trial

GO-FORWARD, a Phase 3, multi-center clinical trial included 444 patients with active RA. Adult patients with more than four tender and swollen joints, despite MTX therapy, were randomly assigned to receive golimumab (50 or 100 mg) plus MTX, golimumab 100 mg plus placebo or placebo plus MTX at weeks 0, 4, 8, 12, 16 and 20. Data were assessed at weeks 14 and 24. The co-primary endpoints were percentage of patients achieving ACR 20 response at week 14 and improvement from baseline in HAQ at week 24.

Golimum
'/>"/>

SOURCE Centocor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 The U.S. Food and ... called the ReShape Integrated Dual Balloon System, that may ... for people with obesity and one or more obesity-related ... Bariatric Surgery (ASMBS), the nation,s largest organization for bariatric ... after careful review the FDA has approved this new ...
(Date:7/29/2015)... and WALTHAM, Mass., July 29, 2015  Shareholder rights ... whether certain officers and directors of AMAG ... to shareholders.  AMAG Pharmaceuticals operates as a specialty ... and cancer supportive care.  The company markets Makena, ... of preterm birth in women with a singleton ...
(Date:7/29/2015)... --  Turing Pharmaceuticals AG announced today that ... its first Chief Communication Officer. In this ... internal and external communications and will provide counsel to ... to Founder and Chairman, Martin Shkreli , and ... "We are excited to have Craig join Turing and ...
Breaking Medicine Technology:American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 2American Society for Metabolic and Bariatric Surgery Views New Balloon Device For Obesity As Bridge Between Medications And Bariatric Surgery 3Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 3
... Seattle Children,s Research Institute ... grant from the Bill & Melinda Gates Foundation ... support device, called Seattle Children,s Positive Airway Pressure (Sea-PAP.) ... Continuous Positive Airway Pressure (B-CPAP) device, will provide breathing ...
... China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced ... announced stocking distributors, OptiMedical Corp. ("OptiMedical") is in the ... as a result has revised its forecast to be ... 2012. Additionally, the Company is negotiating with other stocking ...
Cached Medicine Technology:Seattle Children's Invention Lands Major Funding with Hopes of Saving Thousands of Infant Lives Globally Each Year 2Seattle Children's Invention Lands Major Funding with Hopes of Saving Thousands of Infant Lives Globally Each Year 3Seattle Children's Invention Lands Major Funding with Hopes of Saving Thousands of Infant Lives Globally Each Year 4China Nuvo Solar Target Acquisition SurgLine Updates OptiMedical Corp.'s Sales Forecast in Excess of $10,000,000 2
(Date:7/30/2015)... ... 30, 2015 , ... Addictions Training Institute has announced the launch ... Alcohol and Substance Abuse Counselors. , "We are thrilled to be launching Addictions Training ... shortage of Alcohol and Drug Counselors nationwide. We are excited to be helping ...
(Date:7/29/2015)... ... ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his search for ... art was used for the Charlotte Coliseum show a month later. According to Hawley, ... style concert posters. , They measure 22 x 28 inches and were printed ...
(Date:7/29/2015)... ... July 30, 2015 , ... In ... BOC approved provider of online continuing education courses for Athletic Trainers , ... exclusive Andrews Research and Education Sports Medicine Series. , The new online continuing ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to data released today ... D premium is expected to remain stable at $32.50, a figure far lower than ... D program continues to be a bright spot in American health care. By offering ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to an article published July 23 ... of Health shows exactly what a person needs to do in terms of physical activity ... app will give informed estimates as to the number of calories a person needs to ...
Breaking Medicine News(10 mins):Health News:Addictions Training Institute Announces New Online Certificate Program for Alcohol and Drug Counselors 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3Health News:New NIH Body Weight Planner Illustrates the Need for Reduced Caloric Intake When Trying to Lose Weight, Says Beverly Hills Physicians 2
... A new study provides a novel theory for how ... Center researcher Orrin Devinsky, MD, performed an in-depth analysis ... a consistent pattern of injury to the frontal lobe ... deficits caused by these injuries to the right hemisphere, ...
... than three-quarters of young violent offenders interviewed in two poverty-stricken ... violent incident, a new study reveals. , About half of ... said they had a close friend who died in a ... violence may lead some inner-city youth to accept violence as ...
... & Johnson will host an analyst meeting at 8:30 ... discuss fourth-quarter and full-year 2008 financial results. The meeting ... Chief Executive Officer.Investors and other interested parties may access ... Company,s website at www.investor.jnj.com . , A webcast ...
... Born no larger than a ballpoint pen at birth, ... named the 2009 National Ambassador for the March of Dimes, ... Virginia, was born very early at 25 weeks, weighing less ... only a 5 percent chance of survival. During her five-month ...
... health care , , TUESDAY, Jan. 13 (HealthDay News) -- ... approach adulthood to ensure they receive proper health care as ... Peter Scal of the University of Minnesota, found only about ... such as obtaining health insurance after coming of age. This ...
... 13 Availity, LLC was recognized,as the 2008 ... at the eighth,annual Excellence in Employee Development Awards ... University of North Florida (UNF) Division of ... along with other award winners, at a luncheon ...
Cached Medicine News:Health News:Delusions associated with consistent pattern of brain injury 2Health News:Delusions associated with consistent pattern of brain injury 3Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 2Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 3Health News:Study: Most young violent offenders in two NYC neighborhoods have seen someone killed 4Health News:Micro-Preemie Survives to Become March of Dimes 2009 National Ambassador 2Health News:Micro-Preemie Survives to Become March of Dimes 2009 National Ambassador 3Health News:Availity Achieves Excellence in Blended Learning Award 2
... These versatile enclosures ... with nitrogen or other ... a low-humidity environment. HEPA ... and ionization modules also ...
Ideal for chemical processing that requires downward flow of exhaust fumes. Powderful 1200 CFM blower draws fumes into sub-surface bonded charcoal filter for safe removal of organic vapors (final HEP...
This free-standing work station safely ventilates fumes upwards, away from the work surface. Optional Exhaust Purification System features bonded charcoal filters that remove organic chemical vapors ...
... fume hood ventilates and purifies ... release of exhaust. Bonded charcoal ... Configurations are available with vertical ... final HEPA filter, work bench ...
Medicine Products: